Modular Medical Announces Licensing and Partnership Agreement With Nudge BG

December 19, 2024 4:01 PM

Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to meet the needs of "almost-pumpers" with its user-friendly and affordable design, announced a licensing and partnership agreement with Nudge BG."We are very excited to partner with Modular Medical to bring the next generation of automated insulin delivery ("AID") to the...

Read more

Dr. Joanna Kam Explains How Thick Skin Influences Rhinoplasty Techniques

December 19, 2024 1:30 PM

Dr. Joanna Kam, a renowned facial plastic surgeon, sheds light on the complexities of rhinoplasty for patients with thick skin, offering tailored techniques that provide natural, harmonious results. Double board certified by the American Board of Otolaryngology-Head and Neck Surgery and the American Board of Facial Plastic and Reconstructive Surgery, Dr. Kam at Kam Facial Plastic Surgery is committed to overcoming the unique challenges posed by...

Read more

Fort Lauderdale Medical Waste Disposal Company Responds to Surge in Needlestick Injuries With Key Guide

December 19, 2024 1:11 PM

Due to an increase in needlestick injuries, BioMedical Waste Solutions, a prominent medical waste disposal company, with locations in Fort Lauderdale, FL, is actively working to inform the public about the hazards of improper medical waste disposal, particularly needles.Biomedical Waste The CDC approximates about 385,000 needlestick and sharps-related injuries happen each year among U.S. healthcare workers. This figure could be much higher due...

Read more

Salignostics Secures TGA Approval for Saliva-Based Home Pregnancy Test

December 19, 2024 11:30 AM

Salignostics, a leader in innovative saliva-based diagnostic solutions, proudly announces that its revolutionary saliva-based pregnancy test, Salistick, has received approval from Australia's Therapeutic Goods Administration (TGA). This achievement marks a pivotal step forward for Salignostics, allowing the company to bring its cutting-edge technology to consumers in Australia and New Zealand. Partnering with SGG Solutions, the Australian...

Read more

Sunzen Group Berhad Sees Shareholders Support in AGM with Approval in All 9 Resolutions

December 19, 2024 11:15 AM

Sunzen Group Berhad ("Sunzen" or "the Group"), formally known as Sunzen Biotech Berhad and an established player in Malaysia's health, medical devices and services, and finance sector with a diversified portfolio, successfully concluded its Nineteenth Annual General Meeting ("19th AGM") held at Kota Permai Golf & Country Club, Shah Alam. The AGM saw strong shareholder participation and approval of all resolutions tabled, marking a pivotal...

Read more

Lexaria's Registered GLP-1 Study #4 Begins Dosing

December 19, 2024 9:05 AM

KELOWNA, BC / ACCESSWIRE / December 19, 2024 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces it has begun dosing in the Company's Phase 1b, 12-week chronic study GLP-1-H24-4, (the "Study"). The Study is designed mainly to determine whether Lexaria's proprietary DehydraTECH technology improves the safety and effectiveness of existing GLP-1...

Read more

Zepbound Coupons and Discounts From Duty Free Meds

December 19, 2024 9:00 AM

Zepbound, also known by its main ingredient, trizepatide, and other ground-breaking drugs, like Ozempic, Mounjaro, Rybelsus, Trulicity, and Cialis, can be extremely expensive, even with insurance. New customers can save on their first Duty Free Meds order by easily applying the coupon code " DFM2024 " to their cart at checkout. All new customers are eligible, and the coupon has no expiration date.New and returning customers can also take...

Read more

Rising From the Ashes: Ivy en Rose MedSpa Reopens in San Francisco, Exemplifying Strength and Community Spirit

December 19, 2024 9:00 AM

In a remarkable display of resilience and determination, Ivy En Rose MedSpa is thrilled to announce the grand reopening of its new location, just months after an accidental fire on the upper level destroyed their original space. This milestone marks not just a fresh start for the MedSpa, but also a celebration of unwavering perseverance and the steadfast support of the San Francisco community.For the founder, Arusyak Abrahamyan (Owner of Managed...

Read more

Jaguar Health Announces Import of Coca Leaf From Peru by Joint Venture Magdalena Biosciences for Research in Treating Mental Health Indications

December 19, 2024 9:00 AM

Jaguar Health, Inc.(NASDAQ:JAGX) ("Jaguar") today announced that Magdalena Biosciences, Inc. ("Magdalena"), a joint venture formed by Jaguar and Filament Health Corp. (OTCQB:FLHLF)(Cboe CA:FH)(FSE:7QS) ("Filament" or "Filament Health"), successfully completed an import of six kilograms of coca leaf from Peru to Filament's Metro Vancouver research and development facility. This is the second import of coca leaf into Canada that Magdalena has...

Read more

MIRA Pharmaceuticals Submits IND for Ketamir-2 to FDA, Marking a Significant Milestone in the Company's Pipeline Development

December 19, 2024 9:00 AM

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a preclinical-stage pharmaceutical company focused on developing therapies for neurological and neuropsychiatric disorders, today announced that it has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for Ketamir-2, its novel oral ketamine analog for the treatment of neuropathic pain. The IND submission marks a major step in advancing Mira's lead drug...

Read more

NLS Pharmaceutics and Kadimastem Announce the Submission of a Request by Kadimastem and iTolerance, Inc. for an FDA Pre-IND Meeting for an Innovative Breakthrough Type 1 Diabetes Treatment

December 19, 2024 7:30 AM

NLS Pharmaceutics Ltd. (Nasdaq:NLSP) and Kadimastem Ltd. ("Kadimastem"), a clinical-stage company specializing in "off-the-shelf" allogeneic cell therapy products for neurodegenerative diseases and diabetes, announced today in collaboration with iTolerance, Inc, ("iTolerance") a Miami-based regenerative medicine company, that a request for a Pre-Investigational New Drug ("Pre-IND") meeting has been submitted by Kadimastem and iTolerance to the...

Read more

Black Book Market Research Releases Global Survey Findings on Population Health Applications in Emerging Markets

December 19, 2024 7:00 AM

LONDON, UNITED KINGDOM / ACCESSWIRE / December 19, 2024 / Black Book Market Research, a leading global healthcare technology research firm, has released the findings of an extensive ten-month survey conducted in 2024. The survey engaged 2,525 technology, clinical, and financial leaders across healthcare systems worldwide, including Europe, Asia, Australia, Africa, and South America. The study highlights how nations are leveraging advanced...

Read more

Zomedica Appoints Scott A. Jordan Executive Vice President, Finance & Chief Financial Officer

December 19, 2024 6:30 AM

Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, announced that it has appointed Scott A. Jordan as its Executive Vice President, Finance and Chief Financial Officer, effective January 1, 2025."Scott brings a broad range of skills and experience that will be increasingly important to us as we move forward," said Larry...

Read more

Rising Adoption of Portable Ultrasound Devices in Various Applications and the Growing Demand for Non-invasive, Real-time Diagnostic Tools are Driving the Market for Low-frequency: Future Market Insights, Inc.

December 19, 2024 6:00 AM

The global Low Frequency Ultrasound Market is witnessing significant growth, driven by technological advancements, increasing healthcare demands, and growing applications in diagnostics, therapeutics, and cleaning technologies. From a market value of USD 1,239.1 million in 2025, the sector is projected to reach USD 2,065.1 million by 2035, growing at a steady CAGR of 5.2% during the forecast period from 2024 to 2034.Low-frequency ultrasound is...

Read more

BioNxt Solutions Expands Patent Protection for Drug Delivery Innovations Backed by Positive IPRP

December 19, 2024 3:05 AM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to announce the expansion of its intellectual property portfolio with the filing of new international patents for sublingual delivery technologies targeting autoimmune neurodegenerative diseases.Building upon the positive International Preliminary Report on Patentability (IPRP)...

Read more

Hemogenyx Pharmaceuticals PLC Announces Ultrafast CAR-T Manufacturing

December 19, 2024 2:00 AM

LONDON, UNITED KINGDOM / ACCESSWIRE / December 19, 2024 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical company developing innovative therapies for blood malignancies, and Kure.ai ("Kure"), a leader in ultrafast CAR-T manufacturing technology, are pleased to announce a strategic collaboration to advance the production of CAR-T cell therapies for acute myeloid leukemia (AML) and a subset of acute lymphoblastic leukemia...

Read more

Nature's Answer Introduces PerioBrite(R) Kids Toothpaste - a Gentle Solution for Children's Oral Health With a Delicious Strawberry Taste

December 18, 2024 1:00 PM

Nature's Answer, a leader in botanical health solutions for over five decades, is excited to announce the launch of our PerioBrite® Kids Toothpaste with Xylitol, in a Strawberry Flavor. Specially crafted by dental professionals, this innovative toothpaste combines nature's finest ingredients to promote healthy smiles for children.Dentist-Formulated CareDesigned with both parents and children in mind, PerioBrite® Kids Toothpaste offers a...

Read more

UNOS CEO Urges Congressional Action on Lifesaving Reforms

December 18, 2024 12:45 PM

RICHMOND, VA / ACCESSWIRE / December 18, 2024 / Maureen McBride, Ph.D., the CEO of the United Network for Organ Sharing (UNOS), sent a letter to Congress requesting action on a slate of reforms to our nation's organ donation and transplantation system that will remove barriers, increase efficiency, and reduce organ non-use to help save more lives.The letter was sent to members of the House Committee on Energy and Commerce, which has oversight...

Read more

Cantargia Publishes Strong Preclinical Effects and Clinical Monotherapy Results on Nadunolimab in Pancreatic Cancer in Journal for Immunotherapy of Cancer

December 18, 2024 12:15 PM

LUND, SE / ACCESSWIRE / December 18, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today announced the publication of preclinical and clinical results using the IL1RAP targeted antibody nadunolimab (CAN04) in pancreatic cancer (PDAC). Nadunolimab had pronounced effects on PDAC associated fibroblasts and inhibited recruitment of tumor promoting immune cells. These results were linked to monotherapy data in...

Read more

CORRECTION BY SOURCE: Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONA

December 18, 2024 12:05 PM

SAN DIEGO, CA / ACCESSWIRE / December 18, 2024 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos", or the "Company"), a diversified healthcare company focused on novel AI-powered point-of-care testing ("POCT") and VELDONA ® low-dose interferon therapeutics, is pleased to provide a letter to shareholders from its Chairman of the Board, President, and Chief Executive Officer, Mr. Chun-Hsien (Eddy) Tsai.Dear Shareholders,As 2024 draws to a close, I...

Read more